HPV-NIRD1 (CTMM/Leiden University)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NameHPV-NIRD1 (CTMM/Leiden University)
Drug Alias NameHPV-NIRD1
ClassificationBiologics > Protein drugs > Recombinant polypeptideRadiation-emitting productsVaccines > Application > Therapeutic vaccine
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsPapillomavirus Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryNetherlands
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesLeiden University Medical Center
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCenter For Translational Molecular MedicineLeiden University Medical Center
Active IndicationsN/A
Inactive IndicationsPapillomavirus Infections

Other Information

ATC CodeN/A
Related LinksN/A